Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Accenture
Boehringer Ingelheim
Baxter
UBS
Farmers Insurance

Generated: July 23, 2019

DrugPatentWatch Database Preview

Abciximab - Biologic Drug Details

Try a free trialSee Plans and Pricing

« Back to Dashboard

Summary for abciximab
Tradenames:1
Patents:193
Applicants:1
BLAs:1
Suppliers: see list1
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for abciximab

US Patents for abciximab

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source
Centocor Inc REOPRO abciximab INJECTABLE; INJECTION 103575 001 1994-12-22 ➤ Sign Up HemoSonics LLC (Charlottesville, VA) ➤ Sign Up RX search
Centocor Inc REOPRO abciximab INJECTABLE; INJECTION 103575 001 1994-12-22 ➤ Sign Up INSPIREMD, LTD. (IL) ➤ Sign Up RX search
Centocor Inc REOPRO abciximab INJECTABLE; INJECTION 103575 001 1994-12-22 ➤ Sign Up LOCAL PHARMA, INC. (Las Vegas, NV) ➤ Sign Up RX search
Centocor Inc REOPRO abciximab INJECTABLE; INJECTION 103575 001 1994-12-22 ➤ Sign Up INSPIRE M.D. LTD (Tel Aviv, IL) ➤ Sign Up RX search
Centocor Inc REOPRO abciximab INJECTABLE; INJECTION 103575 001 1994-12-22 ➤ Sign Up ALDERBIO HOLDINGS LLC (Las Vegas, NV) ➤ Sign Up RX search
Centocor Inc REOPRO abciximab INJECTABLE; INJECTION 103575 001 1994-12-22 ➤ Sign Up CureVac AG (Tubingen, DE) ➤ Sign Up RX search
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source

Subscribe to access the full database, or try a Free Trial

Supplementary Protection Certificates for abciximab

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
02C/028 Belgium ➤ Sign Up PRODUCT NAME: ABCIXIMAB; NAT. REGISTRATION NO/DATE: 94 E 0180 19961105; FIRST REGISTRATION: SE 12410 19941111
32/2002 Austria ➤ Sign Up PRODUCT NAME: ABCIXIMAB
C/GB02/039 United Kingdom ➤ Sign Up PRODUCT NAME: ABCIXIMAB, FAB FRAGMENT OF CHIMERIC MONOCLONAL ANTIBODY 7E3; REGISTERED: SE 12410 19941111; UK 08563/0015 19950323
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
McKesson
Chinese Patent Office
Argus Health
Baxter
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.